Skip to main content

Table 5 Characteristics of the use cases

From: Synthesizing evidence from clinical trials with dynamic interactive argument trees

Disease

SRs

No. RCTs

Dimensions {sub-dimensions}

Compared drugs

Glaucoma

Zhang et al. [19]

11

efficacy {IOP reduction}, safety {conjunctival hyperemia}

latanoprost / timolol

T2DM

Rys et al. [20]

9

efficacy {reduction of HbA1c}, safety {hypoglycemia}

insulin glargine / NPH insulin